1. |
王思成, 刘保延, 熊宁宁, 等. 真实世界临床研究伦理问题及策略探讨. 中国中西医结合杂志, 2013, 33(4): 437-442.
|
2. |
付玲, 周学平, 李国春. " 真实世界研究”-中医药科研新思路. 浙江中医药大学学报, 2013, 37(9): 1127-1129.
|
3. |
Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence-what is it and what can it tell us? N Engl J Med, 2016, 375: 2293-2297.
|
4. |
21st Century Cures Act, H. R. 34, 114th Cong. 2015. Available at: https://www.congress.gov/bill/114th-congress/house-bill/34/.
|
5. |
Use of real-world evidence to support regulatory decision- making for medical devices. U. S. Food and Drug Administration. 2017. Available at: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm513027.pdf.
|
6. |
Kramer JM, Schulman KA. Envisioning a transformed clinical trials enterprise in the United States: establishing an agenda for 2020: workshop summary. Appendix F-Discussion paper: transforming the economics of clinical trials. Washington (DC): National Academies Press (US). 2012. Available at: http://www.ncbi.nlm.nih.gov/books/NBK114653/.
|
7. |
张润顺, 王映辉, 刘保延, 等. 基于共享系统的真实世界中医临床研究范式初步实施方案的设计. 中医杂志, 2014, 55(18): 1551-1154.
|
8. |
高毅超, 刘妮波, 郝彧. 基于CNKI数据库对真实世界研究临床应用的文献计量学分析. 中医药导报, 2017, 23(13): 82-85.
|
9. |
董珍宇, 高颖, 吴圣贤. 基于真实世界的松龄血脉康胶囊治疗原发性高血压研究. 中西医结合心脑血管病杂志, 2013, 11(3): 274-275.
|
10. |
付玲, 周学平, 李国春, 等. 中西药联合治疗类风湿关节炎真实世界研究. 中国中西医结合杂志, 2016, 36(11): 1319-1322.
|
11. |
杜婧, 杨薇, 易丹辉, 等. 基于HIS" 真实世界”的丹红注射液治疗冠心病患者合并用药分析. 中国中药杂志, 2011, 36(20): 2821-2824.
|
12. |
招远祺, 冯婧, 招敏娟, 等. 基于真实世界的临床研究方法研究中药注射剂的安全性. 新中医, 2016, 48(9): 160-163.
|
13. |
忻凌, 刘健, 刘春, 等. 基于真实世界的名老中医学术经验数字化平台研究. 中医药管理杂志, 2016, 24(4): 5-7.
|
14. |
Natural Health Products Directorate-Health Canada. Natural Health Product Tracking Survey-2010 final report. Ipsos- Reid. 2011. Available at: http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf.
|
15. |
38% of doctors now suggest natural health products: survey. Canadian Healthcare Network. 2011. Available at: http://www.canadianhealthcarenetwork.ca/pharmacists/clinical/health-indextherapeutics/alternative-medicine/38-of-doctors-now-suggest-naturalhealth-products-survey-11135.
|
16. |
陈章明, 陈敏燕. 香港病患者与中西疗法偏好研究. 紫荆论坛, 2004, 17: 78-83.
|
17. |
Chen KJ, Lu AP. Situation of integrative medicine in China: results from a national survey in 2004. Chin J Integr Med, 2006, 2(3): 161-165.
|
18. |
罗静, 焦阳, 于美丽, 等. 冠心病中西医结合真实世界研究的实践与思考. 北京中医药, 2013, 32(11): 806-810.
|
19. |
Hu Z, Yang X, Ho PC, et al. Herb- drug interactions: a literature review. Drugs, 2005, 65(9): 1239-1282.
|
20. |
Chen KC, Lu R, Iqbal U, et al. Interactions between traditional Chinese medicine and western drugs in Taiwan: a population-based study. Comput Methods Programs Biomed, 2015, 122(3): 462-470.
|
21. |
Kutt A, Girard L, Necyk C, et al. Natural health product- drug interaction tool: a scoping review. Can Pharm J, 2016, 149(2): 75-82.
|
22. |
Necyk C, Khamba B, Chue P, et al. Study of natural health product-drug adverse reactions (S. O. N. A. R.) in patients seeking mental health services. Curr Med Res Opin, 2016, 32(8): 1335-1343.
|
23. |
Cvijovic K, Boon H, Barnes J, et al. A tool for rapid identification of potential herbal medicine-drug interactions. Can Pharm J, 2009, 142(5): 224-227.
|
24. |
Zorzela L, Mior S, Boon H, et al. Tool to assess causality of direct and indirect adverse events associated with therapeutic interventions. Curr Med Res Opin, 2018, 34(3): 407-414.
|
25. |
刘保延, 周雪忠, 李平, 等. 个体诊疗临床科研信息一体化平台. 中国数字医学, 2007, 2(6): 31-36.
|
26. |
De Lusignan S, Crawford L, Munro N. Creating and using real-world evidence to answer questions and about clinical effectiveness. J Innov Health Inform, 2015, 22(3): 368-373.
|